7-139996469-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.1135-10622G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.25 in 151,882 control chromosomes in the GnomAD database, including 4,964 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 4964 hom., cov: 32)

Consequence

TBXAS1
NM_001061.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.608

Publications

5 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.386 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001061.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
NM_001061.7
MANE Select
c.1135-10622G>A
intron
N/ANP_001052.3P24557-1
TBXAS1
NM_001166253.4
c.1273-10622G>A
intron
N/ANP_001159725.2P24557-3
TBXAS1
NM_001130966.5
c.1135-10622G>A
intron
N/ANP_001124438.2P24557-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
ENST00000448866.7
TSL:1 MANE Select
c.1135-10622G>A
intron
N/AENSP00000402536.3P24557-1
TBXAS1
ENST00000336425.10
TSL:1
c.1135-10622G>A
intron
N/AENSP00000338087.7P24557-1
TBXAS1
ENST00000425687.5
TSL:1
c.934-10622G>A
intron
N/AENSP00000388736.1P24557-2

Frequencies

GnomAD3 genomes
AF:
0.251
AC:
38034
AN:
151764
Hom.:
4965
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.297
Gnomad AMI
AF:
0.253
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.260
Gnomad EAS
AF:
0.400
Gnomad SAS
AF:
0.268
Gnomad FIN
AF:
0.214
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.234
Gnomad OTH
AF:
0.238
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.250
AC:
38038
AN:
151882
Hom.:
4964
Cov.:
32
AF XY:
0.247
AC XY:
18329
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.297
AC:
12282
AN:
41392
American (AMR)
AF:
0.170
AC:
2590
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.260
AC:
902
AN:
3470
East Asian (EAS)
AF:
0.400
AC:
2061
AN:
5148
South Asian (SAS)
AF:
0.269
AC:
1297
AN:
4820
European-Finnish (FIN)
AF:
0.214
AC:
2250
AN:
10538
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.234
AC:
15872
AN:
67928
Other (OTH)
AF:
0.236
AC:
497
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1444
2888
4333
5777
7221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.227
Hom.:
4895
Bravo
AF:
0.252
Asia WGS
AF:
0.323
AC:
1124
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
6.7
DANN
Benign
0.68
PhyloP100
0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2267706; hg19: chr7-139696268; API